Skip to main content

Callodine Capital Management, LP

Position in VTRS — Viatris Inc

CIK 1741675 BOSTON, MA

Position in VTRS

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$109,684,204
-$10,840,959 QoQ
Shares Held
8,118,742
-16.1% QoQ
Ownership
0.697%
of shares outstanding
% of Portfolio
7.74%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority Sole 94.68562986728732.ToString("F0")% Shared 0.ToString("F0")% None 5.314370132712678.ToString("F0")%

Common Shares in VTRS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Callodine Capital Management, LP holds $109,684,204 across 1 Drug Manufacturers - Specialty & Generic name. VTRS ranks #1 (100.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VTRS
Viatris Inc
This page
8,118,742 $109,684,204

All Filings in VTRS

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $109,684,204 8,118,742
2025-12-31 $120,525,163 9,680,736
2025-09-30 $68,715,900 6,941,000
2025-06-30 $53,535,350 5,995,000
2025-03-31 $31,573,750 3,625,000
2024-12-31 $34,548,750 2,775,000
2024-09-30 $31,197,567 2,687,129
2024-06-30 $27,021,460 2,542,000
2024-03-31 $27,462,000 2,300,000
2023-12-31 $27,291,600 2,520,000
2023-09-30 $22,875,200 2,320,000
2023-06-30 $21,623,905 2,166,724
2023-03-31 $20,639,411 2,145,469
2022-12-31 $22,487,819 2,020,469
2022-09-30 $14,665,075 1,721,253
2022-06-30 $11,268,578 1,076,273
2022-03-31 $10,608,000 975,000
2021-12-31 $10,612,160 784,343
2021-09-30 $9,891,500 730,000
2021-06-30 $9,816,001 686,914
2021-03-31 $9,875,588 706,914
2020-12-31 $16,210,100 865,000